A pharmacist's role in the individualization of treatment of HIV patients

Personalized Medicine
María Jesús Hernández ArroyoAlfonso Domínguez-Gil Hurlé

Abstract

The pharmacological treatment of HIV is complex and varies considerably among patients, as does the response of patients to therapy, requiring treatment plans that are closely tailored to individual needs. Pharmacists can take an active role in individualizing care by employing their knowledge of pharmacokinetics and pharmacogenetics and by interacting directly with patients in counseling sessions. These strategies promote the following: maintenance of plasma concentrations of antiretroviral agents within therapeutic ranges, prediction of pharmacological response of patients with certain genetic characteristics, and clinical control of HIV through the correct use of antiretroviral treatments. Together, these strategies can be used to tailor antiretroviral therapy to individual patients, thus improving treatment efficacy and safety.

References

Jul 15, 1996·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Oct 8, 1999·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Feb 7, 2001·BMJ : British Medical Journal·C R WolfR L Smith
Jul 6, 2000·Annals of Internal Medicine·D L PatersonN Singh
Nov 23, 2000·AIDS·P L AndersonC V Fletcher
Nov 15, 2001·Journal of Acquired Immune Deficiency Syndromes : JAIDS·M NúñezV Soriano
Apr 12, 2002·Lancet·Seth HetheringtonAllen D Roses
Aug 31, 2002·AIDS Research and Human Retroviruses·Edward P AcostaUNKNOWN Adult Pharmacology Committee of the AIDS Clinical Trials Group
Jun 10, 2003·Clinical Pharmacokinetics·Theodora E M S de Vries-SluijsMarchina E van der Ende
Jul 23, 2003·Current Medicinal Chemistry·C E BaldwinB Berkhout
Oct 9, 2003·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
May 25, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Diane V Havlir, Steven D O'Marro
Sep 1, 2004·Pharmacogenomics·Annalise M MartinSimon Mallal
Nov 17, 2004·Current HIV Research·Philippe ClevenberghJean-François Bergmann
Dec 23, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Franco MaggioloFredy Suter
Apr 13, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sonia Rodriguez-NovoaVincent Soriano
Sep 20, 2005·The Journal of Infectious Diseases·Margalida RotgerUNKNOWN Swiss HIV Cohort Study
Dec 16, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sonia Rodríguez NóvoaVincent Soriano
Jan 5, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Heather J RibaudoUNKNOWN Adult AIDS Clinical Trials Group Study
Feb 24, 2006·Pharmacogenetics and Genomics·Jue WangMagnus Ingelman-Sundberg
Jun 7, 2006·Pharmacogenomics·Julie FoxAlan Winston
Jun 17, 2006·Therapeutic Drug Monitoring·David BackSaye Khoo
Jul 26, 2006·Expert Opinion on Drug Metabolism & Toxicology·Nicola F SmithAlex Sparreboom
Jul 27, 2006·AIDS·Roberto LitteraPaolo Emilio Manconi
Aug 10, 2006·Environmental Monitoring and Assessment·Y ZhangXavier Ruiz
Aug 17, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marylyn D RitchieTimothy R Sterling
Aug 31, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David R Bangsberg
Nov 4, 2006·The Journal of Infectious Diseases·Hassane IzzedineAnd Gilbert Deray

❮ Previous
Next ❯

Software Mentioned

PharmGKB

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved